Drug Shortage Report for RESTORIL
| Report ID | 36518 |
| Drug Identification Number | 00604453 |
| Brand name | RESTORIL |
| Common or Proper name | RESTORIL |
| Company Name | AA PHARMA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | TEMAZEPAM |
| Strength(s) | 15MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100BTL |
| ATC code | N05CD |
| ATC description | HYPNOTICS AND SEDATIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-01-18 |
| Estimated end date | 2018-01-29 |
| Actual end date | 2018-01-31 |
| Shortage status | Resolved |
| Updated date | 2018-04-23 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1165 CREDITSTONE ROAD VAUGHAN, ONTARIO CANADA L4K 4N7 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-01-18 | English | Compare |
| v2 | 2018-01-18 | French | Compare |
| v3 | 2018-01-19 | English | Compare |
| v4 | 2018-04-23 | English | Compare |
| v5 | 2018-04-23 | French | Compare |
Showing 1 to 5 of 5